Pharmaceutical Industry
Moving the EMA to Amsterdam is best for Europe but the worst outcome for the UK
The gene therapy treatment costs $475,000.
A third of the patients could be 'cured'
Key drugs regulator likely to move from UK.
Slammed as "arbitrary" and "dangerous" by health experts.